Chemotherapy-induced Oral Mucositis: Hierarchical Analysis of Recurrence Factors

Overview

Journal Eur Arch Paediatr Dent

Publisher Springer

Specialties Dentistry
Pediatrics

Date 2024 Jul 5

PMID 38969937

Authors

T S de Macedo

M C F de Melo

A K A Ferreira

E L M S da Silva-Selva

G P Godoy

A de F Caldas Junior

Affiliations

Soon will be listed here.

Abstract

Purpose: This study aimed to analyze, through a hierarchical model, the risk factors associated with the recurrence of chemo-induced oral mucositis (OM) in children and adolescents.

Methods: A retrospective cohort with 31 individuals of both sexes, aged 1-18 years, who were undergoing chemotherapy, and presented OM lesions was conducted. Data collection included analysis of medical records, interviews, and intraoral examination. Information regarding patients' socioeconomic and demographic profile, underlying disease, antineoplastic regimen, hematological condition, and oral health status were collected. To assess the association of independent variables with the outcome, the Chi-square, Fisher's Exact, and Mann-Whitney tests were used, in addition to a binary logistic regression model, with a maximum error of 5% and a 95% confidence interval.

Results: Significant associations were observed between the history of OM and the diagnosis of the child/adolescent, neutrophil count, previous cancer treatments and the chemotherapy scheme in use (p < 0.05). Binary logistic regression revealed a 13.69 higher risk of developing OM recurrence in individuals who received high-dose methotrexate (MTX) therapy.

Conclusion: Socioeconomic and demographic factors did not influence OM recurrence. However, clinical variables, such as neutropenia, diagnosis of leukemia, and high-dose MTX protocols increase the chance of OM new cases.

References

Ali S, Salih L, Saeed E . Awareness of medical students about vitamin D deficiency at Ahfad University for women, Sudan. Sudan J Paediatr. 2020; 19(2):117-125. PMC: 6962265. DOI: 10.24911/SJP.106-1574764595. View

Allen G, Logan R, Revesz T, Keefe D, Gue S . The Prevalence and Investigation of Risk Factors of Oral Mucositis in a Pediatric Oncology Inpatient Population; a Prospective Study. J Pediatr Hematol Oncol. 2017; 40(1):15-21. DOI: 10.1097/MPH.0000000000000970. View

Alnuaimi E, Al Halabi M, Khamis A, Kowash M . Oral health problems in leukaemic paediatric patients in the United Arab Emirates: a retrospective study. Eur J Paediatr Dent. 2018; 19(3):226-232. DOI: 10.23804/ejpd.2018.19.03.11. View

Carreon-Burciaga R, Castaneda-Castaneira E, Gonzalez-Gonzalez R, Molina-Frechero N, Gaona E, Bologna-Molina R . Severity of Oral Mucositis in Children following Chemotherapy and Radiotherapy and Its Implications at a Single Oncology Centre in Durango State, Mexico. Int J Pediatr. 2018; 2018:3252765. PMC: 5971240. DOI: 10.1155/2018/3252765. View

Curra M, Gabriel A, Ferreira M, Martins M, Brunetto A, Gregianin L . Incidence and risk factors for oral mucositis in pediatric patients receiving chemotherapy. Support Care Cancer. 2021; 29(11):6243-6251. DOI: 10.1007/s00520-021-06199-5. View

Decker A, Taichman L, DSilva N, Taichman R . Periodontal Treatment in Cancer Patients: An Interdisciplinary Approach. Curr Oral Health Rep. 2018; 5(1):7-12. PMC: 5998810. View

Docimo R, Anastasio M, Bensi C . Chemotherapy-induced oral mucositis in children and adolescents: a systematic review. Eur Arch Paediatr Dent. 2022; 23(4):501-511. DOI: 10.1007/s40368-022-00727-5. View

Donohoe C, Bosi J, Sykes A, Lu Z, Mandrell B . Clinical Characteristics of Children and Adolescents Undergoing Hematopoietic Cell Transplantation Who Develop Oral Mucositis. Oncol Nurs Forum. 2018; 45(4):457-462. PMC: 6152915. DOI: 10.1188/18.ONF.457-462. View

Garrocho-Rangel J, Herrera-Moncada M, Marquez-Preciado R, Tejeda-Nava F, Ortiz-Zamudio J, Pozos-Guillen A . Oral mucositis in paediatric acute lymphoblastic leukemia patients receiving methotrexate-based chemotherapy: case series. Eur J Paediatr Dent. 2018; 19(3):239-242. DOI: 10.23804/ejpd.2018.19.03.13. View

10.

Steiner A, Favre S, Mack M, Hausharter A, Pillet B, Hafner J . Dissecting the Nuclear Import of the Ribosomal Protein Rps2 (uS5). Biomolecules. 2023; 13(7). PMC: 10377357. DOI: 10.3390/biom13071127. View

11.

Heil S . Genetics of high-dose methotrexate-induced oral mucositis: current perspectives. Pharmacogenomics. 2019; 20(9):621-623. DOI: 10.2217/pgs-2019-0062. View

12.

Mohebbi S, I Virtanen J, Murtomaa H, Vahid-Golpayegani M, Vehkalahti M . Mothers as facilitators of oral hygiene in early childhood. Int J Paediatr Dent. 2007; 18(1):48-55. DOI: 10.1111/j.1365-263X.2007.00861.x. View

13.

Nakagaki M, Kennedy G, Gavin N, Clavarino A, Whitfield K . The incidence of severe oral mucositis in patients undergoing different conditioning regimens in haematopoietic stem cell transplantation. Support Care Cancer. 2022; 30(11):9141-9149. PMC: 9410738. DOI: 10.1007/s00520-022-07328-4. View

14.

Parra J, Alvarado M, Monsalve P, Costa A, Montesinos G, Parra P . Oral health in children with acute lymphoblastic leukaemia: before and after chemotherapy treatment. Eur Arch Paediatr Dent. 2019; 21(1):129-136. DOI: 10.1007/s40368-019-00454-4. View

15.

Sajith M, Pawar A, Bafna V, Bartakke S, Subramanian K, Vaidya N . Serum Methotrexate Level and Side Effects of High Dose Methotrexate Infusion in Pediatric Patients with Acute Lymphoblastic Leukaemia (ALL). Indian J Hematol Blood Transfus. 2020; 36(1):51-58. PMC: 7042471. DOI: 10.1007/s12288-019-01144-3. View

16.

Velten D, Zandonade E, Miotto M . Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy. BMC Oral Health. 2017; 17(1):49. PMC: 5251332. DOI: 10.1186/s12903-016-0331-8. View

17.

Yang J, Ye L, Guo L, Zhao Q, Chen R, Luo Y . A nosocomial outbreak of KPC-2-producing Klebsiella pneumoniae in a Chinese hospital: dissemination of ST11 and emergence of ST37, ST392 and ST395. Clin Microbiol Infect. 2013; 19(11):E509-15. DOI: 10.1111/1469-0691.12275. View